Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitors

Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitors

US Patent 11697650 · Granted Jul 11, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Noradrenergic and specific serotonergic anxiolytic and antidepressant, method fo2025
Substituted 3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]tria2024
Copper complexes for treatment of neurodegenerative disorders2024
HCV protease inhibitors2024
Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors2023
Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors2023
Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors2023
Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors2023
Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors2023
Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors2023
Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors2023
Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors2023